TIVDAK is the first and only antibody-drug conjugate (ADC) approved to treat recurrent or metastatic cervical cancer with disease progression on or aft...
Bavarian Nordic Competitors or Alternatives
Bavarian Nordic's top competitors include Symphogen, Genmab and MorphoSys.
Bavarian Nordic VS Symphogen
Symphogen is seen as one of Bavarian Nordic's biggest rivals. Symphogen was founded in 2000 in Ballerup, Other. Like Bavarian Nordic, Symphogen also operates in the Biotechnology sector. Symphogen generates $881M less revenue than Bavarian Nordic.
Looking for similar companies to Bavarian Nordic?
Similar Companies
Companies in Denmark with revenue in $500M-1.0B range
See 42 companies
Companies in Denmark with employees in 1.0-5.0K rangeSee 135 companies
Pharmaceuticals & Biotechnology companies with revenue in $500M-1.0B rangeSee 159 companies
Biotechnology companies with revenue in $500M-1.0B rangeSee 51 companies
Biotechnology companies with employees in 1.0-5.0K rangeSee 115 companies
Biotechnology companies in DenmarkSee 217 companies
Pharmaceuticals & Biotechnology companies in DenmarkSee 371 companies
Pharmaceuticals & Biotechnology companies with employees in 1.0-5.0K rangeSee 399 companies
Companies in Europe with revenue in $500M-1.0B rangeSee 1,890 companies
Trending News for Bavarian Nordic and Bavarian Nordic's Competitors
COPENHAGEN, Denmark, March 31, 2025 Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the f...
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies...
Findings published in The Oncologist underscore the need to account for metastatic site and genomic context in pancreatic cancer trial design MCCLEAN, ...
The authorisation approximately triples the number of patients eligible to receive the therapy...
/PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the 24t...
Bluebird Bio Inc. (NASDAQ: BLUE) shares are trading higher Monday after the company received an unsolicited takeover offer from Ayrmid Ltd. read more...
( MENAFN - GlobeNewsWire - Nasdaq) Company Announcement COPENHAGEN, Denmark; April 1, 2025 - Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 ...
Novartis has scored a win in Korea's reimbursement system, clearing its immunosuppressant Cosentyx (secukinumab) for use in children and teens with chr...
Genmab is active in the field of oncology, with seven treatments on the market to date. These include Darzalex, for multiple myeloma, a bone marrow can...
Frequently Asked Questions about Bavarian Nordic
Who are Bavarian Nordic's top competitors?
Bavarian Nordic's top 3 competitors are Symphogen, Genmab, MorphoSys.Who is similar to Bavarian Nordic?
Symphogen is the most similar to Bavarian Nordic. Genmab and MorphoSys are also similar to Bavarian Nordic.
Are Bavarian Nordic and Symphogen competitors?
Yes, Symphogen is one of Bavarian Nordic’s top competitors.